NasdaqCM - Nasdaq Real Time Price USD
Viking Therapeutics, Inc. (VKTX)
28.00
+0.26
+(0.96%)
As of 9:44:44 AM EDT. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| FOEHR MATTHEW W Director | Conversion of Exercise of derivative security | Apr 11, 2025 | 132,036 |
| LIAN BRIAN Chief Executive Officer | Sale | Jan 6, 2025 | 2,366,570 |
| LIGAND PHARMACEUTICALS, INC. Beneficial Owner of more than 10% of a Class of Security | Sale | Aug 26, 2020 | 5,819,380 |
| MACARTNEY LAWSON Director | Sale | Nov 8, 2024 | 47,965 |
| MANCINI MARIANNA Chief Operating Officer | Sale | Jan 6, 2025 | 374,134 |
| MORNEAU MICHAEL Officer | Stock Award(Grant) | Jan 4, 2021 | 117,747 |
| ROUAN SARAH KATHRYN Director | Purchase | Mar 31, 2025 | 1,240 |
| ROWLAND CHARLES A JR Director | Sale | May 16, 2023 | 30,000 |
| SINGLETON J MATTHEW Director | Sale | Oct 25, 2024 | 9,500 |
| ZANTE GREGORY S Chief Financial Officer | Sale | Jan 6, 2025 | 165,259 |
Related Tickers
IOVA Iovance Biotherapeutics, Inc.
1.7450
-2.51%
AXSM Axsome Therapeutics, Inc.
105.96
+0.27%
ALT Altimmune, Inc.
5.82
+1.04%
MDGL Madrigal Pharmaceuticals, Inc.
294.32
-0.35%
SMMT Summit Therapeutics Inc.
24.45
-0.65%
SRPT Sarepta Therapeutics, Inc.
37.14
+2.58%
TGTX TG Therapeutics, Inc.
33.57
+0.60%
VRTX Vertex Pharmaceuticals Incorporated
429.13
-0.66%
CRSP CRISPR Therapeutics AG
38.41
+3.20%
GPCR Structure Therapeutics Inc.
24.33
+1.84%